Paul Tudor Jones Rallybio Corp Transaction History
Tudor Investment Corp Et Al
- $19.2 Billion
- Q2 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Rallybio Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 10,367 shares of RLYB stock, worth $11,507. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,367Holding current value
$11,507% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RLYB
# of Institutions
68Shares Held
32.2MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$4.66 Million0.02% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$4.04 Million1.68% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$4.03 Million2.28% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$3.66 Million5.39% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$3.36 Million0.1% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $35.7M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...